Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection

Transplantation

Volumn 63, Issue 5, 1997, Pages 646-651

  Galili, Uri ^a   LaTemple, Denise C ^a   Walgenbach, Ann W ^b   Stone, Kevin R ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Stone Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; EPITOPE; GALACTOSE; IMMUNOGLOBULIN G; LAMININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ARTICULAR CARTILAGE; B LYMPHOCYTE ACTIVATION; CARTILAGE GRAFT; CATTLE; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE RESPONSE; KNEE MENISCUS; MONKEY; NONHUMAN; PRIORITY JOURNAL; SWINE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANTIBODIES; CARTILAGE; CATTLE; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GRAFT REJECTION; IMMUNOGLOBULIN G; MACACA FASCICULARIS; MICE; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES;

EID: 0030980701     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703150-00006     Document Type: Article

References (22)

1. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
2. Good H, Cooper DKC, Malcolm AJK, et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant grafting in man. Transplant Proc 1992; 24: 559.
3. Sandrin M, Vaughan HA, Dabkowski PL, McKenzie IFC. Antipig IgM antibodies in human serum react predominantly with Galα1-3Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
4. Collins BH, Cotterell AH, McCurry KR, et al. Cardiac xenografts between primate species provide evidence of the α-galactosyl determinant in hyperacute rejection. J Immunol 1994; 154: 5500.
5. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine to primate cardiac xenografts from human injury. Nature Med 1995; 1: 423.
6. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nature Med 1995; 1: 964.
7. Stone KR, Walgenbach AW, Abrams JT, Nelson J, Gillett N, Galili U. Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection. Transplantation 1997; 63(5): 640.
8. Galili U. Evolution and pathophysiology of the human natural anti-Gal antibody. Semin Immunopathol 1993; 15: 155.
9. Arumugham RG, Hsieh TCY, Tanzer ML, Laine RA. Structures of the asparagine-linked sugar chains of laminin. Biochim Biophys Acta 1986; 883: 112.
10. Gabrielli A, Candel M, Ricciatti AM, Caniglia ML, Wieslander J. Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactose (α1-3)-galactose epitopes. Clin Exp Immunol 1991; 86: 367.
11. Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995; 59: 1549.
12. Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between the anti-Gal antibody and the Galα163Gal epitope in primates. Proc Natl Acad Sci USA 1987; 84: 1369.
13. Galili U, Gregory CR, Morris RE. Contribution of anti-Gal to primate and human IgG binding to porcine endothelial cells. Transplantation 1995; 60: 210.
14. Wang L, Anaraki F, Henion TR, Galili U. Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J Gerontol (Med Sci) 1995; 50A: M227.
15. Rother RP, Fodor WL, Springhorn JP, et al. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J Exp Med 1995; 182: 1345.
16. Galili U, Anaraki F, Thall A, Hill-Black C, Radic M. One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 1993; 82: 2485.
17. Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffis JM. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730.
18. Winand RJ, Anaraki F, Etienne-Decerf J, Galili U. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody: interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid stimulating hormone receptors expressed on mouse cells. J Immunol 1993; 151: 3923.
19. Puthoulakis C, Galili U, Castagliuolo I, et al. A naturally occurring antibody in human sera, anti-Gal IgG binds to the same receptors and mimics some of the effects of C. difficile toxin A in rat colon. Gastroenterology 1996; 110: 1704.
20. Sandrin MS, Fodor WL, Mouthouris E, et al. Enzymatic remodeling of carbohydrate surface of xenogeneic cells substantially reduces human antibody binding and complement mediated cytolysis. Nature Med 1995; 1: 1261.
21. Koike C, Kan-nagi R, Muramatsu T, Yokoyama I, Takagi H. Converting α-Gal epitope of pig into H antigen [Abstract 300]. Third International Congress for Xenotransplantation, Boston, September 1996.
22. Sharma A, Okabe J, Birch P, Martin MJ, Platt JL, Logan JS. Reduction in the level of Gal(α1,3)Gal in transgenic mice and pigs by expression of α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190.